FOS and breast carcinoma: In particular, elevated mRNA levels of c-jun and c-fos have been observed in MCF-7 human breast cancer cells with resistance to doxorubicin as compared to drug-sensitive MCF-7 wild type cells (Daschner et al, 1999).